Epithelial Ovarian Cancer

This page contains recent news articles, when available, and an overview of Epithelial Ovarian Cancer but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Epithelial Ovarian Cancer

BRCA testing in women with familial, personal history of ovarian cancer may ...  -  ‎Oct 29, 2009‎
HemOncTodayTesting all women with invasive nonmucinous epithelial ovarian cancer for BRCA mutations has as great a potential benefit for preventing ovarian and breast ...

What's the evidence for a second round of chemotherapy?  -  ‎Nov 14, 2009‎
guardian.co.ukPhase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a ...

Study highlights limitations of IP drug delivery  -  ‎Oct 29, 2009‎
Oncology UpdateHospital in Melbourne explained that recent trials had supported the use of IP chemotherapy for women with optimally debulked epithelial ovarian cancer. ...

Epithelial ovarian cancer survivors : somatic and mental health, sexuality and ...  -  ‎Oct 28, 2009‎
Kilden Informasjons- og dokumentasjonssenter for kvinne- og kjønnsforskningAstrid Helene Liavaag har i sin avhandling undersøkt hvordan kvinner som har overlevd eggstokkreft, har det etter at behandlingen er ferdig. ...

Surgery is life-saving for some obese people  -  07 Aug 2009
SunJournal.comThe most common kind of ovarian cancer, epithelial ovarian cancer, is a cancer of older women. Bloating, increased abdominal size, fatigue, weight loss,

Ovarian Cancer  -  ‎Aug 5, 2009‎
ADVANCE for LPNsThe risk of epithelial ovarian cancer increases with age, especially after the age of 50. Epithelial ovarian cancer accounts for approximately 10-15 percent

Common ovarian cancer susceptibility locus discovered  -  ‎Aug 6, 2009‎
PHG FoundationA combined analysis of the data from both stages led to the identification of 12 SNPs associated with epithelial ovarian cancer risk (p<10 8 ), all located

Hormone Therapy Use Associated With Increased Risk Of Ovarian Cancer  -  ‎Jul 14, 2009‎
Science Daily (press release)When restricting the analyses to epithelial ovarian cancer, the relative risk among current HT users was 44 percent higher, with previous HT users having a

Is Serum Albumin an Independent Predictor of Survival in Ovarian ...  -  ‎Jul 24, 2009‎
MedscapeAge, stage, grade, and cytology are important prognostic factors in high-risk early-stage epithelial ovarian cancer. [4,5] Performance status,

Abbott, Fujirebio Co-Developing HE4/CA125 Dx to Improve Early ...  -  ‎Jul 29, 2009‎
Pharmacogenomics Reporter...within the European Union to help predict which premenopausal and postmenopausal women are at increased risk for developing epithelial ovarian cancer.

Abbott Lab Says New Diagnostic Biomarker Test Shows Promise In ...  -  ‎Jul 22, 2009‎
RTT NewsA manual form of the HE4 test has been approved by the Food and Drug Association as an aid in estimating the risk of epithelial ovarian cancer in

2009 AAPM Meeting Spotlights Clinical, Physical Advantages of ...  -  ‎Aug 5, 2009‎
Earthtimes (press release)India, assessed the use of TomoTherapy for Whole Abdomen Radiotherapy (WAR) of epithelial ovarian cancer. Their study states that TomoTherapy achieves

PIK3CA alterations in Middle Eastern Ovarian Cancers  -  ‎Jul 28, 2009‎
7thSpace Interactive (press release)However the role of this oncogenic signaling pathway has not been explored in the Middle Eastern epithelial ovarian cancer (EOC).

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ...  -  ‎Jul 20, 2009‎
7thSpace Interactive (press release)We previously described a sub-population of epithelial ovarian cancer (EOC) cells with a functional TLR-4/MyD88/NF-kappaB pathway (Type I EOC cells),

Minimizing obesity’s impact on ovarian cancer survival  -  28 Dec 2008
dBusinessNews Newark (press release),Researchers reviewed the medical records of 304 patients diagnosed with an aggressive form of the disease called epithelial ovarian cancer.

Ovarian cancer survival linked to two key proteins  -  Dec 17, 2008
CNN...in Houston, and colleagues analyzed tissue from 111 women with advanced epithelial ovarian cancer, specifically looking for Dicer and Drosha.

Epithelial ovarian cancer relapsing as isolated lymph node disease ...  -  Dec 12, 2008
7thSpace Interactive (press release),Several evidences suggested that ovarian cancer (OC) patients showing isolated lymph node recurrence (ILNR) have an indolent evolution.

Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New ...  -  Dec 16, 2008
Earthtimes (press release),HE4 in a manual format is currently FDA-cleared for monitoring recurrent or progressive disease in patients with epithelial ovarian cancer (EOC),

IU Simon Cancer Center Researchers Lead Ovarian Cancer Clinical Trial  -  Dec 18, 2008
Medical News Today (press release),Women ages 18 and older who have recurrent epithelial ovarian cancer, primary peritoneal carcinomatosis, or fallopian tube cancer are eligible to

PharmaMar Submits Registration Dossier To The EMEA For Yondelis(R ...  -  Dec 4, 2008
Medical News Today (press release),Epithelial ovarian cancer accounts for 4% of cancers in women and is the fifth leading cause of death by cancer in the female population of developed

RNA extraction, miRNA identification may be useful in ovarian ...  -  Nov 12, 2008
HemOncToday,The study included 28 women with epithelial ovarian cancer and 15 unmatched controls. Prior to surgery, serum was obtained from all patients.

Exiqon Announces Positive Clinical Data From EORTC Clinical Trial ...  -  Oct 27, 2008
MarketWatch...(EORTC) has undertaken a multi-institutional prospective randomized clinical trial on 719 late stage epithelial ovarian cancer patients (named 55971).

Cancers in Women  -  Oct 23, 2008
TheMedGuru,The cancer most commonly forms in the lining of the ovary (resulting in epithelial ovarian cancer) or in the egg cells (resulting in a germ cell tumor).

How Dx-Development Collaboration Between LabCorp and Yale Yielded ...  -  Nov 5, 2008
Biotech Transfer Week,In 2006, LabCorp exclusively licensed the biomarker panel and testing method with the goal of using it to develop a diagnostic for epithelial ovarian cancer

The Miracle Malunggay Plant  -  Oct 29, 2008
Negros Chronicle,It was found out that its anticancer compound can help treat female reproductive disorders like epithelial ovarian cancer. It has anti tumor and hormonal

Clinical Proteomics Advances as Vermillion, LabCorp, Correlogic ...  -  Jun 26, 2008
Proteo Monitor,...this week that the company plans to “shortly�? file for regulatory approval of its OvaCheck test for early detection of epithelial ovarian cancer.

Data Published at ASCO Find Correlation Between ChemoFx(R) Assay ...  -  May 20, 2008
RedOrbit,Patients analyzed in the study had stage II-IV primary epithelial ovarian cancer that was tested by ChemoFx between 1997 and 2003, and received at least one

Thalidomide provide more hope to women diagnosed with Ovarian Cancer  -  May 3, 2008
TopCancerNews.com,Epithelial ovarian cancer is a disease in which cancer cells form in the tissue that covers the ovary. The study evaluated 75 women who were randomly

Regular Aspirin Intake Cuts Breast Cancer Risk  -  May 16, 2008
Medi News Direct,With the purpose of assessing the effects of analgesics in reducing the risk of epithelial ovarian cancer, Schildkraut and coworkers (Epidemiology,

Ovarian cancer hard to detect  -  Apr 30, 2008
LubbockOnline.com,Epithelial ovarian cancer is the most common type and is more common among older women. It is cancer of the surface cells of the ovaries, Richards said.

Green Tea Shown to Reduce Risk of Ovarian and Colorectal Cancers  -  May 6, 2008
Natural News.com,In a population based study in Washington state, 781 women with epithelial ovarian cancer diagnosed between 2002 and 2005, and 1263 controls completed

Learned this week  -  Apr 26, 2008
Vancouver Sun,..."These results bring us closer to more effective and targeted treatment for epithelial ovarian cancer, one of the most lethal forms of cancer," said Gil Mor

ACOG Releases Guidelines on Management of Adnexal Masses  -  May 2, 2008
RedOrbit,The CA 125 antigen level is elevated in 80 percent of patients with epithelial ovarian cancer; however, it is elevated in only 50 percent of patients with

Working Well  -  Apr 28, 2008
Fall River Herald News,Studies have shown that women with epithelial ovarian cancer have elevated levels of HE4, a protein Moore says displays the highest sensitivity for

Criteria for genetic testing  -  Mar 25, 2008
Toronto Star,Ovarian cancer includes invasive forms of epithelial ovarian cancer, primary peritoneal cancer and cancer of the fallopian tubes. 1.

Ovarian Cancer Risk Lower with Longer Time on Pill  -  Mar 21, 2008
Cancerpage.com,The mechanism for the protective influence of oral contraceptives against epithelial ovarian cancer remains unclear, the investigators note.

Bowel Involvement in Advanced Ovarian Cancer Not a Predictor of ...  -  Mar 18, 2008
DG NewsBy Mary Beth Nierengarten CHICAGO -- March 18, 2008 -- Bowel involvement in patients with advanced epithelial ovarian cancer should not preclude a radical

Statin Therapy Appears to Lengthen Survival in Patients With ...  -  Mar 12, 2008
DG News..."This is the first study to suggest that statins have an impact on survival among women with epithelial ovarian cancer biology," Dr. Elmore said.

Neutrophil Count Could Predict Long-Term Outcomes in Ovarian ...  -  Mar 14, 2008
DG NewsDr. Cho and colleagues examined 192 patients with epithelial ovarian cancer, 173 with benign ovarian tumours, 229 with benign gynaecologic disease,

Thalidomide Shows Promise For Treatment Of Recurrent Ovarian ...  -  Feb 27, 2008
Science Daily (press release)Epithelial ovarian cancer is a disease in which cancer cells form in the tissue that covers the ovary. The study evaluated 75 women who were randomly

New Ovarian Cancer Test Now Available in Europe  -  Mar 4, 2008
Business Wire (press release),With the HE4 test, risk for epithelial ovarian cancer is determined by using a mathematical algorithm that combines the HE4 and CA 125 values.

SGO: Statin Use Linked to Survival Benefit in Ovarian Cancer  -  Mar 13, 2008
MedPage Today,..."This is the first study to suggest statins may have significant activity in epithelial ovarian cancer biology," he said.

Thalidomide may treat ovarian cancer  -  Feb 28, 2008
Irish Health,This was then compared with the use of topotecan alone in the treatment of recurrent epithelial ovarian cancer in patients who had received prior treatment.

Refractory Ovarian Cancers Respond to Experimental SNS-595 ...  -  Mar 14, 2008
DG NewsDr. McGuire and colleagues treated 65 women with advanced platinum-resistant epithelial ovarian cancer with progressive disease. In a poster presentation on

Intensifying Treatment With Paclitaxel and Carboplatin Does Not ...  -  Mar 13, 2008
DG News..."In our cohort of women with advanced epithelial ovarian cancer, optimal debulking, rather than dose intensification of adjuvant chemotherapy,

High-Dose Pemetrexed Offers Only Modest Efficacy Compared With Low ...  -  Mar 14, 2008
DG News...[Presentation title: A Randomized Phase II Study of Standard-Versus High-Dose Pemetrexed in Platinum-Resistant Epithelial Ovarian Cancer. Abstract 256]

SGO: Extended Chemotherapy May Reduce Recurrence in Ovarian Cancer  -  Mar 12, 2008
MedPage Today,The trial involved 427 patients with high-risk, early-stage (69% stage I), epithelial ovarian cancer. Following surgical debulking, they were randomized to

SGO: Postop Glucose Spike Predicts Complications in Ovarian Cancer  -  Mar 12, 2008
MedPage Today,The chart examination revealed 171 patients with stage III (90%) or stage IV (10%) epithelial ovarian cancer. During the first 30 postoperative days,

Recurrent Low-grade Carcinoma Of The Ovary Less Responsive To ...  -  Mar 10, 2008
Science Daily (press release)...based on knowledge that this type of epithelial ovarian cancer comprises not one homogenous group of tumors but rather two distinct phenotypes.

BRCA genes and ovarian cancer  -  Feb 28, 2008
Australian Life Scientist,Canadian cancer researchers recently reported that around 18 per cent of women with primary serous epithelial ovarian cancer have germline mutations in the

Malignant Tumor or Benign Cyst?: Researcher from Women & Infants ...  -  Mar 10, 2008
Business Wire (press release),...multiple markers utilizing HE4 and CA 125 and a predictive algorithm could accurately assess the risk for epithelial ovarian cancer prior to surgery.

W&I researcher uses new test for ovarian  -  Mar 12, 2008
Providence Business News,Moore found the ideal protein to test for was HE4, which appears at elevated levels in women with epithelial ovarian cancer. By testing for HE4 and CA125II

Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 ...  -  Mar 10, 2008
Earthtimes,The interim clinical results are being presented in a poster, "A Phase 2 Trial of SNS-595 in Women with Platinum-Refractory Epithelial Ovarian Cancer"

Vermillion Receives Award From the Society of Gynecologic Oncologists  -  Feb 28, 2008
PR Newswire (press release),March 11, from [10:30 am - 6:30 pm ET]: -- Proteomic Markers Increase CA-125 Sensitivity for Early Detection of Epithelial Ovarian Cancer Collaborators:

Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS ...  -  Mar 4, 2008
CNNMoney.com (press release)..."A Phase 2 Trial of SNS-595 in Women with Platinum-Refractory Epithelial Ovarian Cancer"(Abstract # 290), beginning on Sunday, March 9, 2008.

New developments in biomarkers for epithelial ovarian cancer  -  Nov 29, 2007
innovations report,...published by IOS Press, eleven articles explore new developments in the identification and understanding of biomarkers for epithelial ovarian cancer.

Optimal Surgical Removal of Cancer Improves Survival in Advanced ...  -  Dec 7, 2007
Cancer Consultants (press release),Tumor residual after surgical cytoreduction in prediction of clinical outcome in Stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.

Consuming a diet rich in flavonoids may be protective against ...  -  Nov 28, 2007
TopCancerNews.com,In this population, 347 cases of epithelial ovarian cancer were diagnosed between 1984 and 2002. Although total intake of these five common dietary

flavonoid-rich diet helps women decrease risk of ovarian cancer  -  Nov 19, 2007
Science Daily (press release)...luteolin, and apigenin among 66940 women enrolled in the nurses’ health study. in this population, 347 cases of epithelial ovarian cancer were diagnosed

avastin® effective for recurrent ovarian cancer  -  Nov 19, 2007
Cancer Consultants (press release),...in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a gynecologic oncology group study. journal of clinical oncology.

vermillion protein biomarkers help detect early-stage ovarian ...  -  Oct 31, 2007
CNNMoney.com...from 84 patients diagnosed with invasive epithelial ovarian cancer. vermillion collaborated with researchers from the oncologic clinic rigshospitalet,

prolonged paclitaxel infusion does not improve outcomes in ovarian ...  -  Nov 1, 2007
Cancerpage.com,...of paclitaxel from 24 to 96 hours does not significantly improve outcomes in women with suboptimal stage iii or iv epithelial ovarian cancer (eoc),

philippine government set to popularize moringa to boost health ...  -  Nov 3, 2007
AHN...root bark extract has anti-tumor and hormonal properties can help in the treatment of diseases like epithelial ovarian cancer. with its antioxidants,

Background information on Epithelial Ovarian Cancer [When available]

Ovarian cancer is a malignant ovarian neoplasm (an abnormal growth located on the ovaries).

Ovarian cancer is the fourth leading cause of cancer death in women, the leading cause of death from gynecologic malignancies and the second most commonly d

Search the web for more resources on Epithelial Ovarian Cancer

Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

The Cancer News Network


Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

We will do our best to accommodate your request.